Kennedy Capital Management’s Insmed INSM Stock Holding History

Kennedy Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.97M	Buy	55,990 +21,464	+62%	+$2.6M	0.11%	294
2026 Q1	$5.65M	Buy	34,526 +2,477	+8%	+$381K	0.12%	268
2025 Q4	$5.58M	Buy	32,049 +1,695	+6%	+$309K	0.12%	276
2025 Q3	$4.37M	Buy	30,354 +8,457	+39%	+$1.04M	0.1%	319
2025 Q2	$2.2M	Sell	21,897 -12,500	-36%	-$956K	0.05%	430
2025 Q1	$2.62M	Sell	34,397 -1,661	-5%	-$127K	0.06%	397
2024 Q4	$2.49M	Buy	36,058 +23,940	+198%	+$1.72M	0.06%	480
2024 Q3	$885K	Buy	12,118 +2,021	+20%	+$149K	0.02%	603
2024 Q2	$676K	Buy	10,097 +238	+2%	+$9.23K	0.01%	622
2024 Q1	$267K	Buy	+9,859	New	+$276K	0.01%	686

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Kennedy Capital Management's INSM Position: Q2 2026 in Review

Kennedy Capital Management increased its Insmed (INSM) stake by 62% in Q2 2026, buying an estimated $2.6M and bringing the position to 55,990 shares worth $5.97M. The position accounts for 0.11% of the portfolio, ranked #294.

Kennedy Capital Management first reported a position in INSM in Q1 2024 and has held it in 10 quarters since. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Kennedy Capital Management held 55,990 shares of Insmed worth $5.97M as of Q2 2026.
Kennedy Capital Management bought 21,464 Insmed shares in Q2 2026, an estimated $2.6M.
Insmed made up 0.11% of Kennedy Capital Management's portfolio in Q2 2026, its #294 holding.
Kennedy Capital Management first reported a position in Insmed in Q1 2024 and has held it in 10 quarters since.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.